Rhinosinusitis (Chronic Sinusitis) – Comprehensive Medical Guide

Overview

Rhinosinusitis, commonly called chronic sinusitis, is a prolonged inflammation of the nasal cavity and the paranasal sinuses that lasts ≥ 12 weeks despite appropriate medical treatment or Mayo Clinic. The condition can involve both the sinus lining (sinusitis) and the nasal passages (rhinitis), hence the combined term “rhinosinusitis.”

Who it affects: Adults between 30‑60 years are most commonly diagnosed, but children and seniors can also develop chronic rhinosinusitis (CRS). Women appear slightly more likely to be affected (≈55 % of cases) (CDC, 2022).

Prevalence: In the United States, about 12 % of adults (≈30 million people) meet criteria for chronic rhinosinusitis, making it one of the most frequent chronic ENT disorders (NIH, 2020). Worldwide estimates range from 5‑15 %.

Symptoms

Symptoms must be present for at least 12 weeks and often fluctuate. Common features include:

• Nasality and congestion – persistent stuffy nose or “blocked” feeling.
• Purulent or thick nasal discharge – yellow/green mucus that may drip down the back of the throat (post‑nasal drip).
• Facial pain/pressure – especially over the cheeks, forehead, or around the eyes; may worsen when bending forward.
• Reduced sense of smell (hyposmia) or loss of smell (anosmia) – one of the most disabling symptoms.
• Cough – often worse at night due to post‑nasal drip.
• Ear fullness or pressure – eustachian tube dysfunction.
• Bad breath (halitosis) – from stagnant secretions.
• Fatigue and malaise – chronic inflammation can affect overall energy.
• Dental pain – especially upper molar area, can mimic toothache.

When symptoms are present for less than 12 weeks but still cause discomfort, the condition is termed acute rhinosinusitis. Chronic disease may be classified as:

• CRS with nasal polyps (CRSwNP) – visible growths inside the nasal passages.
• CRS without nasal polyps (CRSsNP) – inflammation without polyps.

Causes and Risk Factors

Primary mechanisms

1. Persistent bacterial or fungal infection – often follows an untreated acute sinus infection.
2. Allergic inflammation – allergic rhinitis can cause chronic mucosal swelling.
3. Immune dysfunction – primary immunodeficiencies, HIV, or use of immunosuppressive drugs.
4. Structural abnormalities – deviated septum, concha bullosa, or narrow osteomeatal complex impede drainage.
5. Biofilm formation – colonies of bacteria/fungi adhere to sinus lining, shielding them from antibiotics.

Risk factors

• Age 30‑60 years
• Female gender
• Allergic rhinitis or asthma (especially aspirin‑exacerbated respiratory disease)
• Smoking or exposure to second‑hand smoke
• Chronic exposure to air pollutants or occupational irritants
• Diabetes mellitus, cystic fibrosis, or ciliary dyskinesia
• Previous facial trauma or sinus surgery
• Use of long‑term nasal decongestant sprays (rebound congestion)

Diagnosis

Diagnosis is clinical, supported by imaging and sometimes laboratory tests.

History & Physical Examination

• Detailed symptom timeline (≥12 weeks)
• Endoscopic examination with a nasal speculum or flexible fiberoptic scope to visualize polyps, mucosal edema, purulent secretions.

Imaging

• Computed Tomography (CT) scan of the sinuses – gold standard; shows opacification, bony remodeling, and obstruction. Low‑dose protocols reduce radiation.
• Plain sinus X‑ray – rarely used now due to poor sensitivity.

Laboratory Tests (selected cases)

• Complete blood count – may reveal eosinophilia in allergic or polyposis forms.
• Allergy testing (skin prick or specific IgE) if allergic component suspected.
• Fungal cultures or polymerase chain reaction (PCR) when invasive fungal sinusitis is a concern (immunocompromised patients).
• Blood glucose or HbA1c if diabetes is a contributing factor.

Diagnostic Criteria (per European Position Paper on Rhinosinusitis and Nasal Polyps, EPOS 2020)

• ≥2 of the following symptoms for ≥12 weeks:
  • Nasal blockage or congestion
  • Anterior/post‑nasal discharge
  • Facial pain/pressure
  • Reduced or loss of smell
• Plus either:
  • Endoscopic signs (polyps, mucopurulent discharge, edema) or
  • CT changes (≥1 sinus with > one‑third opacification)

Treatment Options

Therapy combines medical management, lifestyle adjustments, and—when needed—surgical intervention.

Medical Management

1. Saline nasal irrigation – isotonic or hypertonic solution (e.g., NeilMed). Helps clear mucus and reduce crusting. Recommended 2‑3 times daily.
2. Intranasal corticosteroids – first‑line for CRSsNP and CRSwNP (fluticasone, mometasone). Reduces mucosal inflammation and polyp size. Cleveland Clinic.
3. Systemic corticosteroids – short courses (e.g., prednisone 10‑30 mg daily for ≤ 14 days) for severe polyposis or exacerbations; not for long‑term use due to side effects.
4. Antibiotics – indicated when bacterial infection is suspected (purulent discharge, fever, worsening after 3‑4 weeks). Common choices: amoxicillin‑clavulanate 875/125 mg BID for 3 weeks; doxycycline 100 mg daily for 3 weeks in penicillin‑allergic patients. Overuse can promote resistance, so antibiotics are not routine.
5. Antifungal therapy – topical e.g., amphotericin‑B spray for allergic fungal rhinosinusitis; systemic agents only in invasive disease.
6. Leukotriene receptor antagonists (montelukast) – may help patients with aspirin‑exacerbated respiratory disease.
7. Biologic agents – for refractory CRSwNP with eosinophilic inflammation (e.g., dupilumab, omalizumab, mepolizumab). FDA‑approved for adults with CRSwNP who have failed surgery or steroids (JACI, 2021).

Surgical Options

• Functional Endoscopic Sinus Surgery (FESS) – minimally invasive; removes osteomeatal obstruction, polyp tissue, and restores ventilation. Success rates 80‑90 % for symptom relief.
• Balloon Sinuplasty – catheter with inflatable balloon dilates sinus ostia; often combined with medical therapy, especially in mild disease.
• Polypectomy – removal of large polyps during FESS.

Post‑operative care includes continued saline irrigation, topical steroids, and occasional short‑course antibiotics.

Lifestyle & Adjunctive Measures

• Humidify indoor air (30‑50 % relative humidity).
• Avoid known allergens (dust mites, pet dander, mold).
• Quit smoking; limit exposure to second‑hand smoke.
• Manage gastro‑esophageal reflux disease (GERD) which can aggravate sinus inflammation.
• Maintain good oral hygiene to reduce bacterial load that can seed the sinuses.

Living with Rhinosinusitis (chronic sinusitis)

Daily Management Tips

1. Consistent nasal irrigation – use a Neti pot or squeeze bottle with sterile/filtered water. Warm water (body temperature) is most comfortable.
2. Take medications exactly as prescribed – especially nasal sprays; aim the tip slightly outward to avoid crusting.
3. Track triggers – keep a symptom diary noting weather, exposure, diet, and stress levels.
4. Stay hydrated – fluids thin mucus, making drainage easier.
5. Exercise regularly – improves mucociliary clearance.
6. Sleep with head elevation – reduces nighttime congestion.
7. Seek follow‑up – if symptoms persist beyond 4–6 weeks after starting therapy, contact your ENT specialist.

Psychosocial Considerations

Chronic sinusitis can affect sleep, work productivity, and mood. Consider cognitive‑behavioral strategies for stress, and discuss persistent fatigue or depression with a primary care provider. Support groups (both online and in‑person) can provide coping strategies.

Prevention

• Vaccinations – influenza and COVID‑19 vaccines reduce upper‑respiratory infections that can precipitate sinusitis.
• Allergy control – use antihistamines or allergen‑immunotherapy if testing confirms allergies.
• Hand hygiene – reduces viral colds that may trigger acute attacks.
• Proper nasal spray technique – clean nozzle, avoid sharing devices.
• Environmental measures – HEPA filters, regular washing of bedding in hot water (≥ 60 °C) to eliminate dust mites.
• Prompt treatment of acute sinus infections – treat acute bacterial sinusitis early to prevent progression.

Complications

If left untreated, chronic rhinosinusitis can lead to serious sequelae:

• Orbital cellulitis or abscess – infection spreads to eye socket, causing pain, swelling, vision changes.
• Meningitis or brain abscess – rare but life‑threatening intracranial spread.
• Persistent nasal polyps – may cause chronic obstruction, sleep apnea.
• Osteomyelitis of the skull base – infection of bone.
• Reduced quality of life – chronic pain, sleep disturbance, and anosmia can impair daily functioning.
• Secondary asthma exacerbations – especially in patients with aspirin‑exacerbated respiratory disease.

When to Seek Emergency Care

---

Sources: Mayo Clinic, CDC, NIH National Library of Medicine, WHO, Cleveland Clinic, European Position Paper on Rhinosinusitis (EPOS 2020), JACI 2021, and peer‑reviewed sinusitis guidelines.